Scp Investment, LP Amarin Corp Plcuk Transaction History

Scp Investment, LP

$136 Million
Q3 2024

A detailed history of Scp Investment, LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Scp Investment, LP holds 2,500,000 shares of AMRN stock, worth $1.42 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

2,500,000

Previous 2,500,000 -0.0%

Holding current value

$1.42 Million

Previous $1.72 Million 8.64%

% of portfolio

1.16%

Previous 1.1%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 14, 2024	SELL	$0.66 - $0.91 $330,000 - $455,000	-500,000 Reduced 16.67%	2,500,000 $2.18 Million
Q4 2023 Feb 06, 2024	SELL	$0.66 - $0.91 $330,000 - $455,000	-500,000 Reduced 16.67%	2,500,000 $2.18 Million
Q3 2023 Mar 14, 2024	BUY	$0.85 - $1.43 $425,000 - $715,000	500,000 Added 20.0%	3,000,000 $2.76 Million
Q3 2023 Oct 31, 2023	SELL	$0.85 - $1.43 $2.98 Million - $5.01 Million	-3,500,000 Reduced 53.85%	3,000,000 $2.76 Million
Q4 2022 Feb 06, 2023	BUY	$1.07 - $1.34 $2.41 Million - $3.02 Million	2,250,000 Added 52.94%	6,500,000 $7.87 Million
Q3 2022 Oct 25, 2022	BUY	$1.09 - $1.67 $1.64 Million - $2.51 Million	1,500,000 Added 54.55%	4,250,000 $4.63 Million
Q2 2022 Jul 28, 2022	SELL	$1.13 - $3.69 $4.52 Million - $14.8 Million	-4,000,000 Reduced 59.26%	2,750,000 $4.1 Million
Q2 2021 Aug 11, 2021	BUY	$4.26 - $6.5 $5.33 Million - $8.13 Million	1,250,000 Added 22.73%	6,750,000 $29.6 Million
Q4 2020 Feb 12, 2021	BUY	$4.04 - $5.31 $12.1 Million - $15.9 Million	3,000,000 Added 120.0%	5,500,000 $26.9 Million
Q3 2020 Nov 12, 2020	BUY	$3.64 - $7.76 $9.1 Million - $19.4 Million	2,500,000 New	2,500,000 $10.5 Million

Others Institutions Holding AMRN

# of Institutions

178

Shares Held

65.3M

Call Options Held

258K

Put Options Held

98K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $230M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scp Investment, LP, based on Form 13F filings with the SEC.

News

Stay updated on Scp Investment, LP with notifications on news.

Account

Scp Investment, LP Amarin Corp Plcuk Transaction History